CCL20 induces migration and proliferation on breast epithelial cells

Journal of Cellular Physiology

Volumn 228, Issue 9, 2013, Pages 1873-1883

  Marsigliante, Santo ^a   Vetrugno, Carla ^a   Muscella, Antonella ^a  

^a UNIVERSITY OF SALENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CHEMOKINE RECEPTOR CCR6; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROGESTERONE RECEPTOR; PROTEIN C FOS; PROTEIN KINASE B; PROTEIN KINASE C EPSILON;

ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; DNA ISOLATION; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; ONCOGENE C MYC; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL20; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; TUMOR MICROENVIRONMENT;

EID: 84878221110     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24349     Document Type: Article

References (43)

1. Abiko Y, Nishimura M, Kusano K, Nakashima K, Okumura K, Arakawa T, Takuma T, Mizoguchi I, Kaku T. 2003. Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cells carcinoma. Arch Oral Biol 48:171-175.
2. Andre F, Cabioglu N, Assi H, Sabourin JC, Delaloge S, Sahin A, Broglio K, Spano JP, Combadiere C, Bucana C, Soria JC, Cristofanilli M. 2006. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann Oncol 17:945-951.
3. Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA, Banchereau J. 1999. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190:1417-1426.
4. Brand S, Sakaguchi T, Gu X, Colgan SP, Reinecker HC. 2002. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122:166-177.
5. Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Göke B, Dambacher J. 2006. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 97:709-723.
6. Campbell AS, Albo D, Kimsey TF, White SL, Wang TN. 2005. Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion. J Surg Res 123:96-101.
7. Chu IM, Hengst L, Slingerland JM. 2008. The Cdk inhibitor p27 in human cancer: Prognostic potential and relevance to anticancer therapy. Nature Rev Cancer 8:253-267.
8. Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu SV, Salazar EP. 2008. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol 27:220-231.
9. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-867.
10. Descamps S, Lebourhis X, Delehedde M, Boilly B, Hondermarck H. 1998. Nerve growth factor is mitogenic for cancerous but not for normal human epithelial cells. J Biol Chem 273:16659-16662.
11. Dupont J, Le Roith D. 2001. Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: New insights into their synergistic effects. Mol Pathol 54:149-154.
12. Dürig J, Schmücker U, Dührsen U. 2001. Differential expression of chemokine receptors in B cell malignancies. Leukemia 15:752-756.
13. Ebisuya M, Kondoh K, Nishida E. 2005. The duration, magnitude and compartmentalization of ERK MAP kinase activity. Mechanisms for providing signaling specificity. J Cell Sci 118:2997-3002.
14. Geho DH, Bandle RW, Clair T, Liotta LA. 2005. Physiological mechanisms of tumor-cell invasion and migration. Physiology 20:194-200.
15. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C, Keilholz U. 2006. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 24:1910-1916.
16. Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, Thiel E, Christoph F, Miller K, Scheibenbogen C, Keilholz U. 2008. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol 134:1181-1189.
17. Gjorevski N, Nelson CM. 2011. Integrated morphodynamic signalling of the mammary gland. Nat Rev Mol Cell Biol 12:581-593.
18. Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Marsigliante S. 2002. Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells. J Endocrinol 174:205-214.
19. Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S. 2004. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. J Cell Physiol 201:84-96.
20. Greco S, Elia MG, Muscella A, Romano S, Storelli C, Marsigliante S. 2005. Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J Endocrinol 186:291-301.
21. Hart S, Fischer OM, Prenzel N, Zwick-Wallasch E, Schneider M, Hennighausen L, Ullrich A. 2005. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways. Biol Chem 386:845-855.
22. 2 induces proliferation in astrocytoma through the EGF receptor: Another inflammation-cancer link. Neuro Oncol 12:1014-1023.
23. Hiller D, Chu QD. 2011. CXCR4 and axillary lymph nodes: Review of a potential biomarker for breast cancer metastasis. Int J Breast Cancer 2011:420981. DOI: 10.4061/2011/420981.
24. Kimsey TF, Campbell AS, Albo D, Wilson M, Wang TN. 2004. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J 10:374-380.
25. Lazennec G, Richmond A. 2010. Chemokines and chemokine receptors: New insights into cancer-related inflammation. Trends Mol Med 16:133-144.
26. Lebeau A, Müller-Aufdemkamp C, Allmacher C, Sauer U, Nerlich A, Lichtinghagen R, Löhrs U. 2004. Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: Correlation with tumour growth. J Mol Histol 35:443-455.
27. Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, Cattini L, Tonnarelli B, Manferdini C, Facchini A. 2007. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. J Cell Physiol 210:798-806.
28. Mangia A, Malfettone A, Rossi R, Paradiso A, Ranieri G, Simone G, Resta L. 2011. Tissue remodelling in breast cancer: Human mast cell tryptase as an initiator of myofibroblast differentiation. Histopathology 58:1096-1106.
29. Muscella A, Greco S, Elia MG, Storelli C, Marsigliante S. 2002. Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol 173:315-323.
30. Muscella A, Calabriso N, Vetrugno C, Urso L, Fanizzi FP, De Pascali SA, Marsigliante S. 2010. Sublethal concentrations of the platinum(II) complex [Pt(O, O'-acac)(γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells. Br J Pharmacol 160:1362-1377.
31. Muscella A, Calabriso N, Vetrugno C, Fanizzi FP, De Pascali SA, Marsigliante S. 2011a. The signalling axis mediating neuronal apoptosis in response to [Pt(O, O'-acac)(γ-acac)(DMS)]. Biochem Pharmacol 81:1271-1285.
32. Muscella A, Calabriso N, Vetrugno C, Fanizzi FP, De Pascali SA, Storelli C, Marsigliante S. 2011b. The platinum (II) complex [Pt(O, O′-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. Biochem Pharmacol 81:91-103.
33. O'Hayre M, Salanga CL, Handel TM, Allen SJ. 2008. Chemokines and cancer: Migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 409:635-649.
34. Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, Horton LW, Zaja-Milatovic S, Collins-Burow BM, Wadsworth S, Beckman BS, Wood CE, Fuqua SA, Nephew KP, Dent P, Worthylake RA, Curiel TJ, Hung MC, Richmond A, Burow ME. 2011. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res 71:603-613.
35. Rodig SJ, Jones D, Shahsafaei A, Dorfman DM. 2002. CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomas. Hum Pathol 33:1227-1233.
36. Salanga CL, O'Hayre M, Handel T. 2009. Modulation of chemokine receptor activity through dimerization and crosstalk. Cell Mol Life Sci 66:1370-1386.
37. Schutyser E, Struyf S, Van Damme J. 2003. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14:409-426.
38. Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, Martinez-Orozco R, Salazar EP. 2010. Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin Exp Metastasis 27:505-515.
39. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'neill SJ, McElvaney NG. 2005. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med 202:1659-1668.
40. Wang H, Ubl JJ, Stricker R, Reiser G. 2002. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol Cell Physiol 283:C1351-C1364.
41. Werb Z, Ashkenas J, MacAuley A, Wiesen JF. 1996. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz J Med Biol Res 29:1087-1097.
42. Xing C, Imagawa W. 1999. Altered MAP kinase (ERK1, 2) regulation in primary cultures of mammary tumor cells: Elevated basal activity and sustained response to EGF. Carcinogenesis 20:1201-1208.
43. Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I, Ben-Baruch A. 2006. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res 12:4474-4480.